Brace, Lear E http://orcid.org/0000-0001-6961-9758
Vose, Sarah C
Stanya, Kristopher
Gathungu, Rose M
Marur, Vasant R
Longchamp, Alban
Treviño-Villarreal, Humberto
Mejia, Pedro
Vargas, Dorathy
Inouye, Karen
Bronson, Roderick T
Lee, Chih-Hao
Neilan, Edward
Kristal, Bruce S
Mitchell, James R
Article History
Received: 27 August 2015
Revised: 11 June 2016
Accepted: 25 July 2016
First Online: 13 October 2016
Competing interests
: BSK is the inventor on general metabolomics-related IP that has been licensed to Metabolon via Weill Medical College of Cornell University and for which he receives royalty payments via Weill Medical College of Cornell University. He also consults for and has a small equity in the company. Metabolon offers biochemical profiling services and is developing molecular diagnostic assays detecting and monitoring disease. Metabolon has no rights or proprietary access to the research results presented and/or new IP generated under these grants/studies. BSK’s interests were reviewed by the Brigham and Women’s Hospital and Partners Healthcare in accordance with their institutional policy. Accordingly, upon review, the institution determined that BSK’s financial interest in Metabolon does not create a significant financial conflict of interest with this research. The addition of this statement where appropriate was explicitly requested and approved by BWH.